Skip to content

Health / Sun Life Syariah

Salam Healthier Future Assurance (SHIFA) - Signature

Syariah Health agency Full brief · 2026-05-29

Salam Healthier Future Assurance — branded in field collateral as "SHIFA Signature" — is Sun Life Syariah's premium-tier comprehensive health takaful.

★ The Insurer’s Play

analytical interpretation

Why this product exists

To capture recurring health-protection premiums in a fast-growing private-medical market — specifically, to capture whole-household budgets rather than single lives and use a loyalty mechanic to improve persistency and perceived value.

What the insurer wants the agent to do

Steer the agent to bundle several family members onto one policy, lead with the no-claim cashback / loyalty bonus, and position it as a fast private top-up to BPJS, not a replacement.

Inferred from: family-package structureno-claim cashback / loyalty mechanicBPJS positioningPOJK 36/2025 co-paymentaffluent / legacy segmentSyariah / pilgrimage structure

Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.

Who this fits — and who it doesn’t

✓ Fits when…

  • Muslim mass-affluent and affluent households, household income Rp 60M+/month for entry-tier (Indo 1/Indo 2), Rp 120M+/month for Asia tiers, Rp 250M+/month for Asia Plus or Worldwide
  • Age 30–50, head of family, dependants (spouse + 1–3 children), already has BPJS Kesehatan and ideally an employer health card — looking for the genuine private-hospital safety layer that activates without out-of-pocket shock
  • Cross-border footprint: dual-country lifestyle (Jakarta–Kuala Lumpur, Jakarta–Singapore, Surabaya–Penang), children studying overseas, business travel through Asia, or family that flies to Penang/Singapore/Bangkok for medical second opinions
  • Religiously motivated to use syariah financial products and would actively decline a conventional health policy at parity feature
  • Comfortable explaining and accepting Akad Tabarru' / Akad Wakalah bil Ujrah — does not need over-explanation but does want transparency on the Ujrah rate
  • Risk-averse personality on health — willing to pay a premium contribution for the catastrophic-coverage headroom rather than self-insuring with savings/gold/sukuk

~ Borderline — qualify carefully

  • Mass-affluent customer between Rp 30M–60M/month household income — SHIFA Essential, Sun Healthcare Solution Syariah, or AlliSya Flexi Medical Syariah may serve them better at the contribution level. Run the affordability test at insured age 50 and age 60 before writing — annual contributions on Signature escalate with age and Indonesian medical inflation
  • Customer who travels heavily to Singapore, Hong Kong, or Japan but is being shown Indo 1/Indo 2 — those plans reimburse only 15% in those three jurisdictions. Push them up to Asia Plus 1/2 or Worldwide, or do not write
  • Customer with elderly insured (60–70) — entry is allowed up to insured age 70, but the contribution loading will be heavy and the runway to age-100 cap is short
  • Customer already holding Sun Healthcare Solution Syariah or another comprehensive syariah health policy — duplication risk; the coordination-of-benefits clause means the second policy mostly pays the gap, not the headline limit
  • Customer who hesitates on the Wakalah fee disclosure (47–49% Ujrah) — engage the objection in Section 7 before writing; a customer who signs reluctantly on the Ujrah point is a future complaint

✕ Not a fit when…

  • Customers without basic health coverage at all (no BPJS, no employer card) — sell them BPJS Class 1 first; Signature is the wrong entry point
  • Households where premium continuity is at risk (income volatility, recent business stress) — annual contribution escalation plus the 60-day grace lapse rule makes this unforgiving
  • Customers expecting maternity, dental, or routine outpatient coverage — explicitly excluded; outpatient is restricted to the pre-/post-hospitalisation window only
  • Customers with pre-existing conditions in any of the 21 Penyakit Khusus categories listed in the RIPLAY (hypertension, diabetes, kidney disease, all cancers, spinal issues, etc.) — the 12-month exclusion applies from policy inception or reinstatement; high mis-sell and claim-denial risk
  • Customers who explicitly want a CI lump-sum on diagnosis — wrong product; redirect to AlliSya CI Hasanah or pair Signature with a separate CI takaful policy
  • Customers whose syariah preference is loose — they are likely better served by conventional comprehensive products at a lower Ujrah-equivalent cost; do not pitch Signature on syariah branding alone

The trade-offs — when it wins, when it doesn’t

No product wins for everyone. Here’s when Salam Healthier Future Assurance (SHIFA) - Signature is the right call — and when a different product is.

AFFLUENT MUSLIM FAMILY, CROSS-BORDER LIFESTYLE, WANTS US/GLOBAL COVERAGE

Lead:Salam Healthier Future Assurance (Asia Plus 1/2 or Worldwide)

Only Sun Life Syariah health product with full Worldwide-incl-US coverage at 100% reimbursement.

AFFLUENT MUSLIM FAMILY, ASIA-ONLY FOOTPRINT (no US travel/study)

Lead:Salam Healthier Future Assurance (Asia 1 or Asia 2)

Full coverage Malaysia + Asia ex HK/SG/JP; HK/SG/JP at 30% reimbursement. Saves contribution vs Plus tiers.

MASS-AFFLUENT MUSLIM, IDR 30-60M/MONTH HH INCOME, COMPREHENSIVE COVER ONLY

Lead:Sun Healthcare Solution Syariah (sibling)

Lower contribution, Tabarru' ratio similar, plan architecture (Opal-Safir) is better matched to mass- affluent budget; 8-plan tier has Opal entry below SHIFA Signature Indo 1 starting point.

SYARIAH-CONSCIOUS, CONCERN IS 4 KILLER DISEASES ONLY

Lead:SHIFA Essential

CI-triggered health reimbursement at Rp 500M to Rp 2B per year; cheaper than Signature; right structure if cancer/stroke/heart/kidney is the specific anxiety.

SYARIAH PREFERENCE, BUT WANTS GLOBAL HEALTH AND ALLIANZ BRAND

AlliSya is competing in the same segment; check Ujrah rate, network breadth, and global cover details before assuming Signature wins on brand.

BPJS KESEHATAN IS WORKING, CUSTOMER HAS NO ELITE PRIVATE-HOSPITAL NEED

Signature's Rp 4B-15B headroom is over-coverage for households who do not realistically reach premium private wards. Don't write what they don't need.

CUSTOMER ASKS FOR SYARIAH AT BPJS-EQUIVALENT PRICE

Signature is premium; the contribution cannot match BPJS economics.

CUSTOMER PREFERS CONVENTIONAL AT PRICE PARITY, RELAXED ON SYARIAH PURITY

If the syariah preference is soft, conventional may deliver equivalent coverage at a lower effective fee load. Sell on customer fit, not halal branding alone.

CUSTOMER WANTS LUMP-SUM ON CI DIAGNOSIS

Signature reimburses bills only. It does not pay cash on diagnosis.

CUSTOMER ALREADY HAS SUN HEALTHCARE SOLUTION SYARIAH AT TOPAZ PLUS OR HIGHER

Sun Life enforces 1 Signature per insured; coordination-of-benefits rules will dilute payouts.

Key facts

Coverage

  • Annual limit: up to Rp 15 billion (Signature Protection)
  • Limit Booster: up to Rp 35 billion (one-time lifetime benefit)
  • Global coverage including USA
  • Policy term: renewable annually up to age 100

Premium

  • Minimum contribution: Rp 6,304,000/year
  • Payment frequency: monthly / quarterly / semi-annual / annual
  • Payment term: up to age 99

Target Customer

Policyholders aged 18-80; insured members aged 0 (30 days) to 70 years. Mass-affluent segment given premium starting at Rp 6.3M/year.

Key Features

  • Signature Protection: comprehensive care with high annual limits
  • Signature Access: cashless access worldwide
  • Signature Benefit: No Claim Benefit (up to 15% discount next year), Robotic Surgery up to Rp 400M, Traditional Chinese Medicine

⚠ Compliance red flags & mis-selling warnings

These are the issues most likely to generate an OJK complaint or post-sale dispute in the post-POJK-36/2025 environment. Build the agent compliance pack around avoiding all eight.

  1. POJK 36/2025 co-payment regime — applies to all health products including syariah. Effective January 2026, POJK 36/2025 imposes a mandatory co-payment / Risiko Sendiri regime on health insurance and takaful. The Salam Healthier Future Assurance RIPLAY currently published (Agency_v.1/SLFI/2026) does not feature an explicit Sun-Medical-Saver-style per-episode co-payment in the benefit table. Two implications: (a) the only de facto co-pay mechanism today is the room-upgrade prorata clause (if the participant upgrades above the plan room rate, all benefit items are prorated from day one, not just the room) — this MUST be explained at SPAJ stage; (b) a regulatory update to add an explicit co-payment is plausible within 2026 and agents should monitor for a RIPLAY refresh. Do not represent the current absence of an explicit co-pay as a permanent feature. Verify the active RIPLAY version at every fresh sale.

  2. Tabarru’ fund deficit risk disclosure. The Dana Tabarru’ is a finite risk-sharing pool. If claims plus reinsurance costs plus technical-reserve growth exceed contributions in a given period, the fund goes into deficit and Sun Life advances a Qardh (interest-free loan) to cover. Customers must be told: (a) the fund can run a deficit, (b) in such a case, future surplus-sharing pauses until the Qardh is repaid, and © the fund’s resilience depends partly on Sun Life’s willingness and capacity to extend Qardh. This is structurally different from conventional insurance where the insurer’s own balance sheet is the primary backstop. Bury this and you set up a future complaint.

  3. Wakalah bil Ujrah fee transparency. Per-plan Ujrah ranges from 46% to 49% of contribution — at the high end of the syariah health market. POJK syariah insurance regulations require the Tabarru’/Ujrah split to be disclosed in writing in the RIPLAY and verbally to the prospective participant before SPAJ signature. Agents MUST state the applicable percentage for the plan being sold (“for Plan Worldwide, your Ujrah is 49% of contribution, your Tabarru’ contribution is 51%”) and confirm customer understanding. Vague phrasing like “ada biaya pengelolaan” without a number is a compliance violation.

  4. Akad clarity at SPAJ stage. The participant must explicitly affirm both akads at SPAJ signature: Akad Tabarru’ (their contribution is a donation to the risk-sharing pool, not a payment for risk-transfer to Sun Life) and Akad Wakalah bil Ujrah (they are appointing Sun Life as wakil to manage the pool, in exchange for Ujrah). Do not let the customer treat SPAJ as a generic insurance application. The two akads are the basis on which the product is sharia-compliant; missing or unclear akad affirmation can be raised by Dewan Pengawas Syariah and by the participant in dispute.

  5. Premium-tier mis-positioning — Signature pitched to customers who fit Essential or Sun Healthcare Solution. This is the highest-friction mis-selling risk in this product. Salam Healthier Future Assurance is a premium-tier comprehensive health product; its entry contribution at male age 40 is Rp 10.3M/year and tops Rp 20–40M/year at higher tiers and ages. Pitching Signature to a customer whose actual budget and risk fit SHIFA Essential (CI reimbursement) or Sun Healthcare Solution Syariah (mass-affluent comprehensive) is structural mis-selling — driven by the higher commission, not the customer need. Use the Decision Framework in Section 4 as a written documentation trail; if a customer is being placed in Signature when their household income, travel pattern, or stated need doesn’t justify it, document the override rationale.

  6. Global / USA coverage actuarial disclosure. The Worldwide plan’s 100% reimbursement for treatment in the United States is a strong feature, but the actuarial implications must be disclosed: (a) US medical inflation runs materially higher than Indonesian medical inflation and the annual contribution review can move sharply; (b) Sun Life can change the contribution with 30 business days written notice; © the Rp 15B annual limit, while large by Indonesian standards, can be consumed quickly by US oncology, transplant, or NICU treatment — at which point the once-lifetime Limit Booster (up to Rp 35B aggregate ceiling) is the only further headroom. Do not let the customer assume the Worldwide plan is unlimited in any economic sense.

  7. Limit Booster — one-shot lifetime mechanism, not annual. The brochure headline “up to Rp 35 billion” refers to the lifetime cumulative cap including Limit Booster, used once per insured lifetime, and only triggered after the annual ceiling is fully exhausted in a single policy year. It is not a Rp 35B annual fund. Agents who quote “Rp 35 billion” without unpacking the one-shot mechanic are mis-positioning the product. Always pair the headline with: “this is your once-lifetime catastrophic-event backstop, not a yearly figure.”

  8. Product-name dual identity — “Salam Healthier Future Assurance” vs “SHIFA Signature”. Sun Life recently refreshed the consumer-facing brand. Field collateral, social posts, prior-customer policy documents, and the agent quote tool may carry either name. Customers reading the product page today see “Salam Healthier Future Assurance” but may have heard “SHIFA Signature” from a prior conversation or competing agent. Agents must (a) confirm both names refer to the same underwritten product (RIPLAY code Agency_v.1/SLFI/2026, product code PM/B/SHIFA/04/2026), (b) note that the policy document and OJK approval reference are the contractual identifiers — not the marketing name, and © update their own field collateral as Sun Life publishes refreshed material. Until Sun Life issues a successor RIPLAY explicitly closing the product, both names remain valid references to one product.


Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.

Expert · technical detail

Raw fields

Entity type
syariah
Channel
agency
Category
health
Benchmark carrier
no
Extraction quality
medium
First cataloged
2026-05-28
Last updated
2026-05-28
Brief date
2026-05-29
Analyst confidence
Medium-high. RIPLAY and brochure are fully extracted, the benefit table is unambiguous, and Tabarru'/Ujrah splits are disclosed per plan. Source PDFs are unchanged from the 2026-05-20 brief — every quantitative reference below has been previously analyst-verified. Limitations carried forward: only one sample contribution is disclosed (male 40, Plan Indo 1, Rp 10,316,000/yr) so age/gender escalation cannot be quoted in numbers, and competitor Ujrah rates at equivalent tier are not all directly extracted.

How Health products differ

Fully benchmarked · 93% coverage

No product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.

Annual benefit limit qualitative
Rp 250M (entry tier — multiple insurers) Rp 20B (top-tier with auto-increase — Sun Healthcare Safir Plus)

Direct comparison limited by plan-tiering heterogeneity

Renewable to age qualitative

Observed: 80 · 99 · 100

Allianz AlliSya caps at age 80; Sun Healthcare Solution Syariah and Prudential PRUwell Medical Syariah both reach ~age 99-100; longest tail wins for younger entrants

Co-payment (POJK 36/2025) qualitative

POJK 36/2025 effective January 2026 — every health product across the category must apply a co-payment structure. Per-episode vs per-claim vs aggregate annual deductible structures vary; agents must explain the specific mechanism for the product being sold.

Underwriting qualitative
Geographic coverage qualitative

Most insurers offer Indonesia-only at entry tier; ASEAN regional coverage (Malaysia/Singapore) at mid-tier; global coverage at top-tier with reduced reimbursement percentage. Allianz AlliSya Flexi reportedly extends to US coverage at top tier.

Tabarru'/Ujrah split (Syariah) qualitative

Sun Healthcare Solution Syariah: 37-45% Ujrah depending on plan (high end on Opal/Safir). AIA Syariah typically 35-40%. Allianz Syariah varies.

Coverage caveat: Per-product detail extraction is at ~50% coverage across the 36 active health products. Cross-product comparisons in Section 5 of any health brief produced this run rely on qualitative observations and structured peer-product references (Allianz AlliSya line, Prudential PRU lines, and the four Sun Life Syariah briefs already produced — healthcare-solution-syariah, shifa-essential, shifa-signature, salam-anugerah-harapan). (sample: ~30 products)

Expert · full Strategic Brief

1. The 60-Second Pitch

Salam Healthier Future Assurance — branded in field collateral as “SHIFA Signature” — is Sun Life Syariah’s premium-tier comprehensive health takaful. It sits one shelf above SHIFA Essential and a step up from Sun Healthcare Solution Syariah in coverage ceiling and geographic reach. Unlike SHIFA Essential, which is a critical-illness-triggered reimbursement product limited to four killer diseases, Salam Healthier Future Assurance is a general inpatient-and-surgery health product covering all illnesses, with seven plan tiers from Indo 1 (Rp 4 billion annual limit) up to Worldwide (Rp 15 billion annual limit). Every plan adds a one-time Limit Booster on top of the annual limit, taking the lifetime ceiling on a single severe episode up to Rp 35 billion for the Worldwide plan. The product runs on Akad Tabarru’ and Akad Wakalah bil Ujrah, is renewable to insured age 100, covers global treatment including the United States on the top three tiers, and rewards claim-free policyholders with a No-Claim Benefit discount of up to 15% on next-year contribution. In one line: the syariah answer for affluent Indonesian families whose protection question is no longer “will the bill be covered” but “what happens if my child needs cancer treatment in Houston.”


2. Headline Numbers Decoded

The RIPLAY ships with one published sample case — male age 40, Plan Indo 1, annual contribution Rp 10,316,000. The block below decodes that case plus the cross-plan ceilings agents will actually quote in the field.

Critical reading on Limit Booster: the brochure marketing leans on the headline “up to Rp 35 billion” (Worldwide), but Limit Booster is once per insured lifetime, single shot, and only triggered after the annual ceiling is fully exhausted in that policy year. It is a catastrophic-event backstop, not an annual benefit. Agents must explain this; surfacing only the Rp 35B figure is mis-positioning.

Critical reading on the sample contribution: Rp 10,316,000 is for entry-tier Indo 1 at male 40. The Worldwide plan, female 40, or insured ages 50+, 60+ will be materially higher. Without published age-tier tables, agents must quote only via the actual SPAJ quoting tool — not by extrapolating from the brochure.

Critical reading on the rebrand: the new product page header reads “Salam Healthier Future Assurance” — the field-facing name on agent collateral and consumer-facing material may still read “SHIFA Signature.” Be deliberate at SPAJ: the policy document and binding contract carry the Sun Life-assigned product code (PM/B/SHIFA/04/2026); the marketing name is not the contractual identifier. Treat both names as referring to the same underwritten product until Sun Life issues a successor RIPLAY explicitly closing the old product.


SAMPLE CASE (RIPLAY)

Insured

Male, 40, non-smoker

Plan

Indo 1 (entry tier)

Annual contrib

Rp 10,316,000

Death benefit

Rp 20,000,000

Coverage term

To insured age 100

(annual renewable)

Geography

Indonesia only

ANNUAL LIMIT BY PLAN

Indo 1

Rp 4,000,000,000

Indo 2

Rp 5,000,000,000

Asia 1

Rp 6,000,000,000

Asia 2

Rp 7,000,000,000

Asia Plus 1

Rp 8,000,000,000

Asia Plus 2

Rp 10,000,000,000

Worldwide

Rp 15,000,000,000

LIMIT BOOSTER (LIFETIME, ONCE)

Triggered only after the full annual

limit for the policy year is used.

Boost takes the policy year ceiling

up to

Indo 1

Rp 8,000,000,000

Indo 2

Rp 12,000,000,000

Asia 1

Rp 15,000,000,000

Asia 2

Rp 17,500,000,000

Asia Plus 1

Rp 20,000,000,000

Asia Plus 2

Rp 30,000,000,000

Worldwide

Rp 35,000,000,000

Note

once-in-a-lifetime, single

shot. Does not refresh each year.

ROOM RATE (MAX/DAY)

Indo 1

Rp 600,000

(twin-bed ward)

Indo 2

Rp 1,100,000

(single-bed)

Asia 1

Rp 700,000

(twin-bed)

Asia 2

Rp 1,200,000

(single-bed)

Asia Plus 1

Rp 1,100,000

(twin-bed)

Asia Plus 2

Rp 1,650,000

(single-bed)

Worldwide

Rp 2,500,000

(single-bed)

Cap

365 days/policy yr

GEOGRAPHIC REIMBURSEMENT %

(Out-of-area, all reimbursement

not cashless)

Plan Indo 1 / Indo 2

Malaysia:70% of approved

Asia ex HK/SG/JP/ID/MY:50%

HK/Singapore/Japan:15%

Worldwide ex US:10%

United States:5%

Emergency cap:Rp 50M/yr

Plan Asia 1 / Asia 2

Malaysia:100%

Asia ex HK/SG/JP/ID/MY:100%

HK/Singapore/Japan:30%

Worldwide ex US:15%

United States:10%

Emergency cap:Rp 100M/yr

Plan Asia Plus 1 / Asia Plus 2

Malaysia:100%

Asia ex HK/SG/JP/ID/MY:100%

HK/Singapore/Japan:100%

Worldwide ex US:60%

United States:30%

Emergency cap:Rp 150M/yr

Plan Worldwide

All geographies:100% (including US)

NO-CLAIM BENEFIT (NCB)

Discount on next-year contribution

No claim 1 yr:5% off

No claim 2 yrs:10% off

No claim 3+ yrs:15% off

Resets on any approved claim.

Lapse + reinstatement disqualifies

NCB for that policy year; benefit

can re-accrue from next anniversary.

TABARRU' / UJRAH SPLIT

Indo 1

53% Tabarru' / 47%

Indo 2

54% / 46%

Asia 1

52% / 48%

Asia 2

54% / 46%

Asia Plus 1

52% / 48%

Asia Plus 2

54% / 46%

Worldwide

51% / 49%

Reading

~half of contribution

enters the Dana Tabarru' (risk-

sharing pool). The other half is

Ujrah — Sun Life's management fee

for acting as wakil (agent) of the

participant. Worldwide plan has

the highest Ujrah at 49%.

Policy print fee

Rp 150,000 if

hardcopy elected.

SURPLUS UNDERWRITING SHARE

If the Tabarru' pool finishes the

year in surplus (after Qardh

repayment, claims, reinsurance,

technical reserves)

Pemegang Polis:50%

Pengelola:40%

Dana Tabarru':10%

Conditions

policy >=12 months

old, zero claims in period, all

contributions paid, policy still

active at payout date. Surplus

share below Rp 50,000 is donated

to a licensed social institution.

=== BROCHURE SCENARIO (LIMIT

BOOSTER MECHANICS) ===

Plan Indo 1, year 2 (1 May 2026

to 30 April 2027).

Annual limit start:Rp 4.0B

Limit Booster pool:Rp 8.0B

Claims paid to date:Rp 3.18B

Remaining year limit:Rp 820M

New 3-day inpatient:Rp 1.5B

Annual limit consumed:Rp 4.0B

Limit Booster used:Rp 680M

Limit Booster left:Rp 7.32B

Year 3 reset

Annual limit refresh:Rp 4.0B

Limit Booster pool:Rp 7.32B (does NOT refresh)

3. Ideal Customer Profile

Sweet Spot — Lead with Salam Healthier Future Assurance

  • Muslim mass-affluent and affluent households, household income Rp 60M+/month for entry-tier (Indo 1/Indo 2), Rp 120M+/month for Asia tiers, Rp 250M+/month for Asia Plus or Worldwide
  • Age 30–50, head of family, dependants (spouse + 1–3 children), already has BPJS Kesehatan and ideally an employer health card — looking for the genuine private-hospital safety layer that activates without out-of-pocket shock
  • Cross-border footprint: dual-country lifestyle (Jakarta–Kuala Lumpur, Jakarta–Singapore, Surabaya–Penang), children studying overseas, business travel through Asia, or family that flies to Penang/Singapore/Bangkok for medical second opinions
  • Religiously motivated to use syariah financial products and would actively decline a conventional health policy at parity feature
  • Comfortable explaining and accepting Akad Tabarru’ / Akad Wakalah bil Ujrah — does not need over-explanation but does want transparency on the Ujrah rate
  • Risk-averse personality on health — willing to pay a premium contribution for the catastrophic-coverage headroom rather than self-insuring with savings/gold/sukuk

Borderline Fit — Qualify carefully before proceeding

  • Mass-affluent customer between Rp 30M–60M/month household income — SHIFA Essential, Sun Healthcare Solution Syariah, or AlliSya Flexi Medical Syariah may serve them better at the contribution level. Run the affordability test at insured age 50 and age 60 before writing — annual contributions on Signature escalate with age and Indonesian medical inflation
  • Customer who travels heavily to Singapore, Hong Kong, or Japan but is being shown Indo 1/Indo 2 — those plans reimburse only 15% in those three jurisdictions. Push them up to Asia Plus 1/2 or Worldwide, or do not write
  • Customer with elderly insured (60–70) — entry is allowed up to insured age 70, but the contribution loading will be heavy and the runway to age-100 cap is short
  • Customer already holding Sun Healthcare Solution Syariah or another comprehensive syariah health policy — duplication risk; the coordination-of-benefits clause means the second policy mostly pays the gap, not the headline limit
  • Customer who hesitates on the Wakalah fee disclosure (47–49% Ujrah) — engage the objection in Section 7 before writing; a customer who signs reluctantly on the Ujrah point is a future complaint

Do Not Pitch

  • Customers without basic health coverage at all (no BPJS, no employer card) — sell them BPJS Class 1 first; Signature is the wrong entry point
  • Households where premium continuity is at risk (income volatility, recent business stress) — annual contribution escalation plus the 60-day grace lapse rule makes this unforgiving
  • Customers expecting maternity, dental, or routine outpatient coverage — explicitly excluded; outpatient is restricted to the pre-/post-hospitalisation window only
  • Customers with pre-existing conditions in any of the 21 Penyakit Khusus categories listed in the RIPLAY (hypertension, diabetes, kidney disease, all cancers, spinal issues, etc.) — the 12-month exclusion applies from policy inception or reinstatement; high mis-sell and claim-denial risk
  • Customers who explicitly want a CI lump-sum on diagnosis — wrong product; redirect to AlliSya CI Hasanah or pair Signature with a separate CI takaful policy
  • Customers whose syariah preference is loose — they are likely better served by conventional comprehensive products at a lower Ujrah-equivalent cost; do not pitch Signature on syariah branding alone

4. Decision Framework

Rule of thumb: if the prospect’s first sentence contains “berobat ke luar negeri” (treatment abroad), “anak sekolah di Singapore/US” (child studying overseas), “syariah dong” (syariah only), and household income clearly clears Rp 100M+/month, Salam Healthier Future Assurance is in the conversation — most likely an Asia Plus or Worldwide tier. If their first sentence contains “yang murah aja” (just the cheap one), “BPJS kayaknya cukup” (BPJS is probably enough), or “saya cuma butuh untuk kalau kena kanker” (I just need cover for cancer), Signature is the wrong door — redirect.


AFFLUENT MUSLIM FAMILY, CROSS-BORDER LIFESTYLE, WANTS US/GLOBAL COVERAGE

Lead:Salam Healthier Future Assurance (Asia Plus 1/2 or Worldwide)

Only Sun Life Syariah health product with full Worldwide-incl-US coverage at 100% reimbursement.

AFFLUENT MUSLIM FAMILY, ASIA-ONLY FOOTPRINT (no US travel/study)

Lead:Salam Healthier Future Assurance (Asia 1 or Asia 2)

Full coverage Malaysia + Asia ex HK/SG/JP; HK/SG/JP at 30% reimbursement. Saves contribution vs Plus tiers.

MASS-AFFLUENT MUSLIM, IDR 30-60M/MONTH HH INCOME, COMPREHENSIVE COVER ONLY

Lead:Sun Healthcare Solution Syariah (sibling)

Lower contribution, Tabarru' ratio similar, plan architecture (Opal-Safir) is better matched to mass- affluent budget; 8-plan tier has Opal entry below SHIFA Signature Indo 1 starting point.

SYARIAH-CONSCIOUS, CONCERN IS 4 KILLER DISEASES ONLY

Lead:SHIFA Essential

CI-triggered health reimbursement at Rp 500M to Rp 2B per year; cheaper than Signature; right structure if cancer/stroke/heart/kidney is the specific anxiety.

SYARIAH PREFERENCE, BUT WANTS GLOBAL HEALTH AND ALLIANZ BRAND

AlliSya is competing in the same segment; check Ujrah rate, network breadth, and global cover details before assuming Signature wins on brand.

BPJS KESEHATAN IS WORKING, CUSTOMER HAS NO ELITE PRIVATE-HOSPITAL NEED

Signature's Rp 4B-15B headroom is over-coverage for households who do not realistically reach premium private wards. Don't write what they don't need.

CUSTOMER ASKS FOR SYARIAH AT BPJS-EQUIVALENT PRICE

Signature is premium; the contribution cannot match BPJS economics.

CUSTOMER PREFERS CONVENTIONAL AT PRICE PARITY, RELAXED ON SYARIAH PURITY

If the syariah preference is soft, conventional may deliver equivalent coverage at a lower effective fee load. Sell on customer fit, not halal branding alone.

CUSTOMER WANTS LUMP-SUM ON CI DIAGNOSIS

Signature reimburses bills only. It does not pay cash on diagnosis.

CUSTOMER ALREADY HAS SUN HEALTHCARE SOLUTION SYARIAH AT TOPAZ PLUS OR HIGHER

Sun Life enforces 1 Signature per insured; coordination-of-benefits rules will dilute payouts.

5. Product Benchmarking — vs the health category

The Indonesian agency health category catalogues 36 products at the agency-only gate as of 2026-05-29, with PDF coverage at 98% (category-inventory-status: ready_for_analysis=true). Cross-product quantitative thresholds across all measurable metrics remain below 60% — comparisons below are qualitative against the documented peer set, with strongest direct cross-references to two sibling products in the same insurer (Sun Healthcare Solution Syariah and SHIFA Essential) and the most-comparable Allianz AlliSya product.


STRUCTURAL DIMENSIONS

PRODUCT TYPE

Salam Healthier Future Assurance

(SHIFA Signature): Comprehensive health (all conditions); inpatient + surgery + limited outpatient + death benefit

SHIFA Essential:CI-triggered health reimbursement (4 cond.) Sun Healthcare Soln Syariah: Comprehensive health, 8 plan tiers Allianz AlliSya Flexi Medical: Comprehensive health

Read:Signature is in the same product class as Sun Healthcare Solution and AlliSya Flexi but at the high end of plan ceiling.

ANNUAL LIMIT RANGE

Salam Healthier Future Assurance:Rp 4B-15B Sun Healthcare Soln Syariah: Rp 250M-10B (Opal to Safir Plus before auto-increase) Allianz AlliSya Flexi Medical: varies by plan

Read:Signature's floor (Rp 4B) is higher than the ceiling of many mass-market syariah health plans. This is a premium-tier product by design.

LIMIT BOOSTER (LIFETIME ONE-OFF)

Salam Healthier Future Assurance:Yes, up to Rp 35B aggregate (Worldwide) Sun Healthcare Soln Syariah: Auto-increasing annual limit (different mechanic - yearly, not catastrophic)

AlliSya:Not documented at equivalent level

Read:Limit Booster is a catastrophic-event backstop; it is structurally different from Sun Healthcare's annual auto-increase. Agents must not conflate the two.

RENEWAL CEILING

Salam Healthier Future Assurance:To insured age 100, annual renewable Sun Healthcare Soln Syariah: To age 100

Allianz AlliSya Flexi:To 80

Read:Sun Life Syariah's age-100 renewal is its category lead vs Allianz.

ENTRY AGE

Salam Healthier Future Assurance

insured:30 days - 70 years

Policyholder:18 - 80 years Sun Healthcare Soln Syariah

insured:3 months - 70 years

Read:Signature is one of the few syariah health products catering to infant insureds from 30 days old.

GEOGRAPHIC REACH

Salam Healthier Future Assurance:Indonesia, Asia, Asia Plus (incl HK/SG/JP at 100%), Worldwide (incl US at 100% on top tier only) Sun Healthcare Soln Syariah: Indonesia + Malaysia + SG on Safir; out-of-area reimbursement 30-100%

AlliSya Flexi:Indonesia + global at some plans

Read:Signature's Worldwide tier with full US coverage at 100% is uncommon in the syariah health space and is a clear competitive moat at the affluent end.

UNDERWRITING

Salam Healthier Future Assurance:Full medical underwriting expected at higher SAs; simplified at entry-tier subject to plan and age Sun Healthcare Soln Syariah: Simplified, no medical exam

Read:Signature is the more medically-underwritten cousin; expect Sun Financial Check Up to be required for Asia Plus and Worldwide tiers.

ECONOMIC DIMENSIONS

ANNUAL CONTRIBUTION (PUBLISHED)

Salam Healthier Future Assurance

minimum:Rp 6,304,000/yr Sample (Indo 1, male 40): Rp 10,316,000/yr Sun Healthcare Soln Topaz Plus (male 40 brochure): Rp 5,931,000/yr

Read:Signature entry contribution is roughly 2x its closest sibling at the same age band. This is consistent with its higher annual limit and global reach.

CO-PAYMENT (POJK 36/2025)

Salam Healthier Future Assurance:No explicit Sun-Medical-Saver- style per-episode co-pay in the RIPLAY benefit table. Room-upgrade prorata clause functions as de facto co-pay. Sun Healthcare Soln Syariah: Mandatory Sun Medical Saver co-payment Rp 8M-20M per episode by plan

Read:This is a significant structural difference. Signature does not impose the per-episode co-pay that Sun Healthcare charges. POJK 36/2025 effective Jan 2026 requires co-payment for all health products - agents should expect Signature to be updated to add an explicit co- payment clause by mid-2026 or to be reclassified under POJK exemption provisions. Verify at quote stage.

NO-CLAIM BENEFIT (NCB)

Salam Healthier Future Assurance:5% / 10% / 15% discount on next-yr contribution after 1/2/3+ claim-free years Sun Healthcare Soln Syariah: Not standard

AlliSya Flexi:Varies

Read:NCB up to 15% is a meaningful retention feature and acts as a soft floor on the contribution at older ages. Agents must disclose that the discount resets on any approved claim.

CONTRIBUTION ESCALATION

Salam Healthier Future Assurance:Reviewed at each policy anniversary; not guaranteed; 30 business days written notice required before change effective Sun Healthcare Soln Syariah: Same - escalation with age

AlliSya:Same

Read:This is industry-standard for health takaful/insurance. No syariah-specific advantage here; agents must disclose.

ROOM RATE BENCHMARKING

Salam Healthier Future Assurance

Indo 1:Rp 600K/day twin-bed

Sun Healthcare Soln Opal:Rp 500K/ day twin OR cheapest double

Read:Comparable at entry tier. Worldwide plan room rate (Rp 2.5M/ day single-bed) is high relative to typical syariah health peers, consistent with the global tier.

SHARIA-SPECIFIC DIMENSIONS

AKAD STRUCTURE

Salam Healthier Future Assurance:Akad Tabarru' (risk-sharing donation pool) + Akad Wakalah bil Ujrah (Sun Life as wakil managing fund for a fee). Sun Healthcare Soln Syariah: Same two akads.

AlliSya:Same two akads (typical for Indonesian health takaful).

Read:Structurally aligned with the market norm. The compliance burden is on disclosure quality, not on akad uniqueness.

TABARRU' / UJRAH SPLIT

Salam Healthier Future Assurance

by plan:

Indo 1:53% / 47% Indo 2, Asia 2, Asia Plus 2: 54% / 46%

Asia 1, Asia Plus 1:52% / 48%

Worldwide:51% / 49% Sun Healthcare Soln Syariah:

Topaz:61% / 39%

Emerald:63% / 37%

Opal:55% / 45%

Safir:56% / 44%

Read:Signature's Ujrah rates (46-49%) are higher than Sun Healthcare's mid-tiers. The Worldwide plan's 49% Ujrah is at the high end of the syariah health market. Agents must surface this transparently - customers comparing siblings WILL notice and ask.

SURPLUS UNDERWRITING NISBAH

Salam Healthier Future Assurance:Polis 50% / Pengelola 40% / Dana Tabarru' 10% Sun Healthcare Soln Syariah: Same nisbah.

Read:Standardised within Sun Life Syariah. Surplus payout is conditional (zero claims, policy >=12 months, contribs paid, policy active at payment). Below Rp 50K threshold goes to social institution - same rule.

QARDH (INTEREST-FREE LOAN

IN DEFICIT)

Salam Healthier Future Assurance:Sun Life provides Qardh if Dana Tabarru' runs deficit; must be repaid from future surplus before fresh surplus sharing. Standard for the segment.

Read:This is a structural feature of takaful - fund health depends partly on Sun Life's willingness and capacity to extend Qardh. Disclose, do not obscure.

POLICIES PER INSURED LIMIT

Salam Healthier Future Assurance:1 per insured. Sun Healthcare Soln Syariah: Same - 1 per insured.

Read:Cannot stack two Signature policies on one insured; check existing book before writing.

POLICY PRINT UJRAH

Salam Healthier Future Assurance:Rp 150,000 if hardcopy elected.

Read:Disclose at SPAJ stage; small but mandatory item.

OJK REGULATORY POSITION

Sun Life Indonesia Syariah:RBC Syariah 220% (as at 30 Sept 2025) vs 120% min; 16 KPM Syariah offices nationwide; total assets Rp 19.74T (audited)

Read:Solvency margin is well above the floor. Worth quoting to customers who probe insurer strength.

POSITIONING SUMMARY

Salam Healthier Future Assurance

occupies the premium-tier slot

in the Sun Life Syariah health

stack

SHIFA Essential is the

CI-focused entry point, Sun

Healthcare Solution Syariah is

the mass-affluent comprehensive

cover, and Salam Healthier Future

Assurance is the affluent /

global-mobility tier.

STRENGTHS

- Annual limit floor Rp 4B is

higher than the ceiling of

many syariah peers

- Worldwide plan with full US

coverage at 100% - uncommon

in syariah health

- Limit Booster (once-lifetime)

adds catastrophic-event head-

room up to Rp 35B

- Renewable to insured age 100

- No-Claim Benefit up to 15%

discount is a retention tool

many syariah peers lack

- Cashless via Preferred Hospital

network in Indonesia and

partner network abroad

WEAKNESSES / FRICTION

- Ujrah rates (46-49%) are at

the high end of the syariah

health market; the Worldwide

plan's 49% is the headline-

worst against Sun Healthcare

Emerald's 37%

- Limit Booster is once-per-

lifetime, not per-year;

brochure positioning is

prone to over-promise

- No explicit Sun Medical Saver

co-payment disclosed today -

POJK 36/2025 conformity

expected to require update;

uncertainty for new policies

written in 2026

- Single sample contribution

disclosed; agent quote tool

required for any real number

- One policy per insured caps

household stacking on the

syariah side of the Sun Life

product portfolio

- Mass-market entry not viable

- entry contribution is

~Rp 10M+/yr; budget customers

must be redirected

- Brand-name dual identity

(marketing name vs prior name

"SHIFA Signature") creates

agent-customer disambiguation

friction until field

collateral consolidates

RELATIVE POSITIONING

vs SHIFA Essential

Different

product class - Essential is

CI-only reimbursement;

Signature is comprehensive.

Not direct substitutes; can

be stacked but check household

economics.

vs Sun Healthcare Solution

Syariah:Same product class, Signature is the premium tier with global reach. Sun Healthcare Topaz Plus and Emerald Plus are the lower-priced fallbacks for mass-affluent customers whose budget doesn't clear the Signature entry point.

vs AlliSya Flexi Medical Syariah

Allianz is the closest external

competitor at the syariah-

comprehensive-health shelf.

Signature wins on renewal

ceiling (100 vs 80) and global

reach; verify Allianz Ujrah

vs Signature's 46-49% at quote.

vs BPJS Kesehatan

Complementary

not substitutive. Customers

hold BPJS as base, Signature

as private-hospital premium

layer.

6. Field Talking Points (EN + ID)

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

Opening — establish the right frame

“Most syariah health products in the market are designed for the middle income — they work, but they cap out exactly where the bills get serious. Salam Healthier Future Assurance — many of you may still know it as SHIFA Signature; Sun Life refreshed the brand name recently — is designed for families whose protection question isn’t ‘will the hospital bill be covered’ — it’s ‘what happens if my child needs specialist treatment in Singapore, or surgery in the US’. That’s a different conversation, and it needs a different product.”

“Kebanyakan produk kesehatan syariah di pasar didesain untuk kelas menengah — fungsinya jalan, tapi batasnya habis tepat saat tagihannya mulai serius. Salam Healthier Future Assurance — banyak yang mungkin masih kenal namanya SHIFA Signature, Sun Life baru-baru ini menyegarkan brand-nya — didesain untuk keluarga yang pertanyaannya bukan lagi ‘tagihan rumah sakitnya ke-cover nggak’ — tapi ‘kalau anak saya butuh perawatan spesialis di Singapura, atau operasi di Amerika, gimana’. Itu pembicaraan yang beda, dan butuh produk yang beda.”

The structural value prop (annual limit + Limit Booster)

“Two things make this product different. First — your annual limit on the entry plan is Rp 4 billion, and on the top plan it’s Rp 15 billion. That resets every year. Second — if you ever have a catastrophic year and burn through that annual limit, the Limit Booster kicks in once in your lifetime and gives you up to Rp 35 billion of extra capacity. Think of it as your one-shot safety net for the worst-case medical event.”

“Ada dua hal yang bikin produk ini beda. Pertama — batas tahunan Anda di plan paling dasar itu Rp 4 miliar, dan di plan paling atas Rp 15 miliar. Ini reset setiap tahun. Kedua — kalau Anda mengalami tahun yang sangat berat dan limit tahunannya habis, Limit Booster aktif sekali seumur hidup dan menambah kapasitas sampai Rp 35 miliar. Anggap saja ini jaring pengaman sekali tembak untuk skenario kesehatan paling buruk.”

The global coverage pitch (Asia Plus / Worldwide)

“If your family travels, your children study overseas, or you take serious medical decisions to Singapore or Penang — the Worldwide plan covers your treatment anywhere in the world at 100%, including the United States. That’s a feature you will not find in most syariah health products in this market. Asia Plus is the step below — full coverage across Asia including Hong Kong, Singapore, and Japan, but the US drops to 30% reimbursement.”

“Kalau keluarga Anda sering bepergian, anak-anak studi di luar negeri, atau Anda biasa ambil keputusan medis serius di Singapura atau Penang — plan Worldwide ini cover perawatan Anda di mana saja di dunia 100%, termasuk Amerika Serikat. Ini fitur yang tidak akan Anda temukan di kebanyakan produk kesehatan syariah di pasar ini. Asia Plus tingkat di bawahnya — cover penuh seluruh Asia termasuk Hong Kong, Singapura, dan Jepang, tapi untuk Amerika turun ke 30% penggantian.”

The Tabarru’ / Wakalah disclosure (lead with it, do not bury)

“Before we go further — let me explain how the structure works, because it matters. Salam Healthier Future Assurance uses two Islamic contracts. Akad Tabarru’ means your contribution joins a shared risk pool with other participants; claims are paid from that pool, not from Sun Life’s own balance sheet. Akad Wakalah bil Ujrah means Sun Life acts as the wakil — the appointed manager — of that pool, and charges a transparent fee for that service. On your plan, that fee is around 46–49% of your contribution. The rest — 51–54% — enters the Tabarru’ pool. This is disclosed in writing in the RIPLAY; I am not hiding it.”

“Sebelum kita lanjut — saya jelaskan dulu strukturnya, karena ini penting. Salam Healthier Future Assurance pakai dua akad Islam. Akad Tabarru’ artinya kontribusi Anda masuk ke dana bersama dengan peserta lain; klaim dibayarkan dari dana itu, bukan dari neraca Sun Life. Akad Wakalah bil Ujrah artinya Sun Life jadi wakil — pengelola yang ditunjuk — untuk dana itu, dan mengambil fee yang transparan untuk jasa pengelolaan. Di plan Anda, fee itu sekitar 46–49% dari kontribusi. Sisanya — 51–54% — masuk ke dana Tabarru’. Ini diungkapkan tertulis di RIPLAY; saya tidak menyembunyikan.”

The No-Claim Benefit narrative

“There is one more thing built into this product that I want you to know about. If you don’t claim for one year, you get a 5% discount on next year’s contribution. Two years claim-free, 10%. Three years or more, 15%. So in a sense, your discipline and good health are rewarded. The discount resets if you do file a claim — that’s fair, because that year the pool covered you.”

“Ada satu hal lagi yang built-in di produk ini yang ingin saya sampaikan. Kalau Anda nggak klaim selama satu tahun, Anda dapat diskon 5% untuk kontribusi tahun berikutnya. Dua tahun tanpa klaim, 10%. Tiga tahun atau lebih, 15%. Jadi disiplin dan kesehatan Anda dihargai. Diskon-nya reset kalau Anda klaim — itu fair, karena tahun itu Anda sudah ditanggung dana bersama.”

Handling the brand-name question (if customer reads “Salam Healthier Future Assurance” on the page but expected “SHIFA”)

“Quick note on the name — Sun Life recently refreshed the brand from ‘SHIFA Signature’ to ‘Salam Healthier Future Assurance’. Same product, same policy code, same underwriter, same benefits. The agent collateral and the new product page reflect the new name; older marketing material may still say SHIFA Signature. When you sign the policy, the official product code ‘PM/B/SHIFA/04/2026’ is the contractual identifier — both names refer to it. If you ever have a doubt, look for that code on any policy document.”

“Sedikit catatan soal nama — Sun Life baru saja menyegarkan brand dari ‘SHIFA Signature’ menjadi ‘Salam Healthier Future Assurance’. Produknya sama, kode polisnya sama, underwriter-nya sama, manfaatnya sama. Materi agen dan halaman produk baru pakai nama baru; materi lama mungkin masih tertulis SHIFA Signature. Saat Anda tanda tangan polis, kode produk resmi ‘PM/B/SHIFA/04/2026’ yang jadi identitas kontraktualnya — dua nama itu merujuk ke produk yang sama. Kalau ragu, lihat saja kode itu di dokumen polis.”

The close (against Sun Healthcare Solution as the obvious step-down)

“If the contribution at this tier turns out to be a stretch, we don’t force the fit. Sun Healthcare Solution Syariah from the same insurer covers you at the mass-affluent shelf with the auto-increasing annual limit feature — a different mechanic but solid coverage for the Indonesia and regional context. Salam Healthier Future Assurance is the right product when global reach and Rp 4–15 billion annual headroom genuinely match your situation. Want me to run the actual quote for your age band on both, so you can compare side by side?”

“Kalau kontribusi di tier ini terasa berat, kita nggak paksakan. Sun Healthcare Solution Syariah dari penanggung yang sama cover Anda di kelas mass-affluent dengan fitur batas tahunan yang naik otomatis — mekanik beda tapi coverage-nya solid untuk konteks Indonesia dan regional. Salam Healthier Future Assurance itu produk yang tepat saat coverage global dan kapasitas Rp 4–15 miliar per tahun memang sesuai situasi Anda. Mau saya bandingkan ilustrasi kontribusi sebenarnya di usia Anda untuk keduanya, supaya bisa lihat berdampingan?”

7. Top 5 Customer Objections + Handling

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

1. “Is it really halal — what about the risk that the Dana Tabarru’ runs into deficit?”

Customer “Beneran halal nggak sih ini — kalau Dana Tabarru’-nya defisit gimana?”

Don't say “It’s halal, just trust me — there’s no risk.” — dismisses a genuine theological question.

Don't say “Halal kok, percaya aja — nggak ada risikonya.”

Do say “Good question — and I want to answer it directly. Salam Healthier Future Assurance uses Akad Tabarru’ (mutual risk-sharing donation) and Akad Wakalah bil Ujrah (Sun Life as your appointed manager for a disclosed fee). The deficit scenario is real and real takaful products are designed for it: if claims exceed contributions plus reserves in a given year, Sun Life provides a Qardh — an interest-free loan — to cover the shortfall. That Qardh is then repaid from future Tabarru’ surpluses before fresh surplus sharing resumes. So the pool is protected, but you should know the structural fact: a deficit shifts the load to Sun Life’s capacity to extend Qardh. Sun Life Syariah’s RBC is 220% as of September 2025 — well above the 120% regulatory floor — so the buffer is healthy today. But I won’t tell you the structure is risk-free. It isn’t. It’s a takaful structure, and you should know exactly how it works.”

Do say “Pertanyaan bagus — saya jawab langsung. Salam Healthier Future Assurance pakai Akad Tabarru’ (saling tolong-menolong, kontribusi sebagai hibah ke dana bersama) dan Akad Wakalah bil Ujrah (Sun Life sebagai wakil pengelola, dengan fee yang transparan). Skenario defisit memang ada dan produk takaful yang benar memang didesain untuk itu: kalau klaim di satu periode melebihi kontribusi plus cadangan, Sun Life kasih Qardh — pinjaman tanpa bunga — untuk menutup. Qardh-nya nanti dilunasi dari surplus Tabarru’ tahun-tahun berikutnya sebelum surplus baru dibagikan. Jadi dana-nya terlindungi, tapi Anda perlu tahu faktanya: defisit menggeser beban ke kapasitas Sun Life untuk kasih Qardh. RBC Syariah Sun Life saat ini 220% per September 2025 — jauh di atas batas minimum 120% — jadi buffer-nya sehat. Tapi saya tidak akan bilang strukturnya bebas risiko. Tidak. Ini struktur takaful, dan Anda berhak tahu persis cara kerjanya.”

2. “Why not just BSI’s takaful — they’re the syariah-bank brand?”

Customer “Kenapa nggak BSI takaful aja — kan brand bank syariah?”

Don't say “BSI products are inferior.” — alienates the customer who likely banks at BSI.

Don't say “Produk BSI kurang bagus.”

Do say “BSI Asuransi Syariah is a legitimate option, and many of my clients hold BSI products for general syariah health coverage at the mass-market tier. Where Salam Healthier Future Assurance is different is the ceiling: annual limit Rp 4–15 billion, plus a one-time Limit Booster of up to Rp 35 billion, plus Worldwide coverage including the US at 100% on the top plan. If your need is general hospitalisation at Indonesian private hospitals, BSI may serve you fine and at lower contribution. If your need is the catastrophic-scenario layer — global treatment, surgery overseas, multi-year cancer therapy — that’s where Signature is structurally built. They serve different purposes; for some customers, both make sense.”

Do say “BSI Asuransi Syariah itu opsi yang sah, dan banyak klien saya pegang produk BSI untuk coverage kesehatan syariah umum di tingkat mass-market. Bedanya Salam Healthier Future Assurance ada di plafonnya: batas tahunan Rp 4–15 miliar, plus Limit Booster sekali seumur hidup sampai Rp 35 miliar, plus coverage Worldwide termasuk Amerika 100% di plan teratas. Kalau kebutuhan Anda rawat inap umum di RS swasta Indonesia, BSI mungkin cukup dan kontribusinya lebih ringan. Tapi kalau kebutuhan Anda lapisan untuk skenario katastrofik — perawatan global, operasi di luar negeri, terapi kanker multi-tahun — di situ Signature memang dibangun strukturnya. Beda tujuan; untuk sebagian nasabah, dua-duanya masuk akal.”

3. “The premium is too high vs Essential — why not just take Essential and save money?”

Customer “Premi-nya kemahalan dibanding Essential — kenapa nggak ambil Essential aja yang lebih hemat?”

Don't say “Essential isn’t enough — you need Signature.” — fights the customer’s budget question instead of clarifying the product difference.

Don't say “Essential nggak cukup — Anda harus Signature.”

Do say “These are not two grades of the same product — they’re two different products. SHIFA Essential is critical-illness-triggered reimbursement: it activates only for stroke, cancer, cardiovascular, or kidney failure, and pays bills up to Rp 500M–2B per condition per year. Salam Healthier Future Assurance is general comprehensive health: it activates for any covered illness, and the annual limit is Rp 4–15 billion. If you’re worried specifically about the four killer diseases and your other health risk is manageable, Essential is the right product and the lower cost is rational. If you want comprehensive cover — appendicitis, road accidents, surgery for anything covered by the policy — then you need this product, not Essential. Let me ask: what’s the actual scenario you’re trying to protect against?”

Do say “Dua produk ini bukan dua kelas dari produk yang sama — beda produk. SHIFA Essential itu reimbursement yang dipicu penyakit kritis: aktif hanya untuk stroke, kanker, jantung, atau gagal ginjal, dan bayar tagihan sampai Rp 500 juta–2 miliar per kondisi per tahun. Salam Healthier Future Assurance itu kesehatan komprehensif: aktif untuk semua penyakit yang ditanggung polis, dan batas tahunannya Rp 4–15 miliar. Kalau yang Anda khawatirkan khusus empat penyakit pembunuh itu dan risiko kesehatan lainnya manageable, Essential memang produk yang tepat dan hemat itu rasional. Kalau Anda mau coverage komprehensif — usus buntu, kecelakaan, operasi apapun yang masuk polis — Anda butuh produk ini, bukan Essential. Boleh saya tanya: skenario sebenarnya yang ingin Anda lindungi itu apa?”

4. “I’d rather save and pay cash for medical bills — gold and sukuk give me liquidity I can actually use.”

Customer “Mendingan saya nabung sendiri buat biaya medis — emas dan sukuk kasih saya likuiditas yang beneran bisa dipakai.”

Don't say “Your savings won’t be enough.” — patronising, and probably wrong about a specific affluent customer.

Don't say “Tabungan Anda nggak akan cukup.”

Do say “I respect that — self-insuring with liquid syariah-compliant assets is a real strategy and it works at certain wealth levels. Let me reframe the question. If you’re comfortable that your gold and sukuk position can absorb a Rp 5–10 billion bill for a cancer treatment that runs across multiple countries and three years, then self-insure. But ask yourself: when that bill arrives, do you really want to liquidate your sukuk allocation at whatever price the market gives you that month? Or do you want a structure where the bill is paid first and your sukuk stays intact, compounding? Salam Healthier Future Assurance is not a savings substitute — it’s a liquidity-protection mechanism. The Tabarru’ pool absorbs the bill so your invested capital stays invested.”

Do say “Saya hormati pemikirannya — self-insure pakai aset syariah likuid itu strategi yang nyata dan jalan di level kekayaan tertentu. Tapi izinkan saya reframe. Kalau Anda yakin posisi emas dan sukuk Anda bisa nyerap tagihan Rp 5–10 miliar untuk perawatan kanker lintas negara selama tiga tahun, ya silakan self-insure. Tapi tanya pada diri sendiri: pas tagihan itu datang, apakah Anda benar-benar mau cairkan alokasi sukuk Anda di harga pasar bulan itu? Atau Anda lebih suka struktur di mana tagihannya dibayar duluan dan sukuk Anda tetap utuh, berbunga compound? Salam Healthier Future Assurance bukan pengganti tabungan — ini mekanisme proteksi likuiditas. Dana Tabarru’ yang nyerap tagihan, supaya modal Anda yang sudah diinvestasikan tetap di tempat dan terus tumbuh.”

5. “What’s the actual difference vs Healthcare Solution Syariah — they sound the same?”

Customer “Sebenarnya bedanya apa sih sama Healthcare Solution Syariah — kedengarannya mirip?”

Don't say “Signature is just the better one.” — vague and dismissive; the customer is asking a sharp question.

Don't say “Signature itu yang lebih bagus.”

Do say “They’re both comprehensive syariah health products from Sun Life, and they overlap. Three real differences: One — Salam Healthier Future Assurance’s annual limit floor is Rp 4 billion; Sun Healthcare Solution starts at Rp 250 million (Opal) and tops out at Rp 10 billion. Signature is positioned higher. Two — Signature has the Worldwide tier with US coverage at 100%; Sun Healthcare Solution caps regionally at Indonesia + Malaysia + Singapore (Safir tier). Three — Sun Healthcare Solution has a mandatory Sun Medical Saver co-payment of Rp 8M–20M per hospitalisation episode; Signature today does not have an explicit per-episode co-pay in the published benefit table. There’s also a contribution gap — Signature entry is roughly twice Sun Healthcare Solution at the same age. For an Indonesia-focused mass-affluent customer, Sun Healthcare Solution is often the right pick. For a globally-mobile affluent customer, Signature is. If you’re not sure which describes you, I’d rather we work through that question than push a tier.”

Do say “Dua-duanya produk kesehatan syariah komprehensif dari Sun Life, dan memang overlap. Tiga perbedaan riilnya: Pertama — batas tahunan Salam Healthier Future Assurance mulai dari Rp 4 miliar; Sun Healthcare Solution mulai dari Rp 250 juta (Opal) sampai Rp 10 miliar (Safir). Signature posisinya lebih tinggi. Kedua — Signature punya tier Worldwide dengan coverage Amerika 100%; Sun Healthcare Solution batas regionalnya Indonesia + Malaysia + Singapura (Safir). Ketiga — Sun Healthcare Solution wajib pakai Sun Medical Saver, co-payment Rp 8–20 juta per episode rawat inap; Signature di tabel manfaat saat ini belum ada co-payment per-episode yang eksplisit. Ada juga selisih kontribusi — Signature kira-kira 2x Sun Healthcare Solution di usia yang sama. Untuk nasabah mass-affluent yang fokus Indonesia, Sun Healthcare Solution sering jadi pilihan yang tepat. Untuk nasabah affluent yang mobile global, Signature jawabannya. Kalau belum yakin mana yang gambarin Anda, mendingan kita jalanin diskusinya bareng — saya nggak dorong tier sembarangan.”

8. Compliance Red Flags & Mis-Selling Warnings

These are the issues most likely to generate an OJK complaint or post-sale dispute in the post-POJK-36/2025 environment. Build the agent compliance pack around avoiding all eight.

  1. POJK 36/2025 co-payment regime — applies to all health products including syariah. Effective January 2026, POJK 36/2025 imposes a mandatory co-payment / Risiko Sendiri regime on health insurance and takaful. The Salam Healthier Future Assurance RIPLAY currently published (Agency_v.1/SLFI/2026) does not feature an explicit Sun-Medical-Saver-style per-episode co-payment in the benefit table. Two implications: (a) the only de facto co-pay mechanism today is the room-upgrade prorata clause (if the participant upgrades above the plan room rate, all benefit items are prorated from day one, not just the room) — this MUST be explained at SPAJ stage; (b) a regulatory update to add an explicit co-payment is plausible within 2026 and agents should monitor for a RIPLAY refresh. Do not represent the current absence of an explicit co-pay as a permanent feature. Verify the active RIPLAY version at every fresh sale.

  2. Tabarru’ fund deficit risk disclosure. The Dana Tabarru’ is a finite risk-sharing pool. If claims plus reinsurance costs plus technical-reserve growth exceed contributions in a given period, the fund goes into deficit and Sun Life advances a Qardh (interest-free loan) to cover. Customers must be told: (a) the fund can run a deficit, (b) in such a case, future surplus-sharing pauses until the Qardh is repaid, and © the fund’s resilience depends partly on Sun Life’s willingness and capacity to extend Qardh. This is structurally different from conventional insurance where the insurer’s own balance sheet is the primary backstop. Bury this and you set up a future complaint.

  3. Wakalah bil Ujrah fee transparency. Per-plan Ujrah ranges from 46% to 49% of contribution — at the high end of the syariah health market. POJK syariah insurance regulations require the Tabarru’/Ujrah split to be disclosed in writing in the RIPLAY and verbally to the prospective participant before SPAJ signature. Agents MUST state the applicable percentage for the plan being sold (“for Plan Worldwide, your Ujrah is 49% of contribution, your Tabarru’ contribution is 51%”) and confirm customer understanding. Vague phrasing like “ada biaya pengelolaan” without a number is a compliance violation.

  4. Akad clarity at SPAJ stage. The participant must explicitly affirm both akads at SPAJ signature: Akad Tabarru’ (their contribution is a donation to the risk-sharing pool, not a payment for risk-transfer to Sun Life) and Akad Wakalah bil Ujrah (they are appointing Sun Life as wakil to manage the pool, in exchange for Ujrah). Do not let the customer treat SPAJ as a generic insurance application. The two akads are the basis on which the product is sharia-compliant; missing or unclear akad affirmation can be raised by Dewan Pengawas Syariah and by the participant in dispute.

  5. Premium-tier mis-positioning — Signature pitched to customers who fit Essential or Sun Healthcare Solution. This is the highest-friction mis-selling risk in this product. Salam Healthier Future Assurance is a premium-tier comprehensive health product; its entry contribution at male age 40 is Rp 10.3M/year and tops Rp 20–40M/year at higher tiers and ages. Pitching Signature to a customer whose actual budget and risk fit SHIFA Essential (CI reimbursement) or Sun Healthcare Solution Syariah (mass-affluent comprehensive) is structural mis-selling — driven by the higher commission, not the customer need. Use the Decision Framework in Section 4 as a written documentation trail; if a customer is being placed in Signature when their household income, travel pattern, or stated need doesn’t justify it, document the override rationale.

  6. Global / USA coverage actuarial disclosure. The Worldwide plan’s 100% reimbursement for treatment in the United States is a strong feature, but the actuarial implications must be disclosed: (a) US medical inflation runs materially higher than Indonesian medical inflation and the annual contribution review can move sharply; (b) Sun Life can change the contribution with 30 business days written notice; © the Rp 15B annual limit, while large by Indonesian standards, can be consumed quickly by US oncology, transplant, or NICU treatment — at which point the once-lifetime Limit Booster (up to Rp 35B aggregate ceiling) is the only further headroom. Do not let the customer assume the Worldwide plan is unlimited in any economic sense.

  7. Limit Booster — one-shot lifetime mechanism, not annual. The brochure headline “up to Rp 35 billion” refers to the lifetime cumulative cap including Limit Booster, used once per insured lifetime, and only triggered after the annual ceiling is fully exhausted in a single policy year. It is not a Rp 35B annual fund. Agents who quote “Rp 35 billion” without unpacking the one-shot mechanic are mis-positioning the product. Always pair the headline with: “this is your once-lifetime catastrophic-event backstop, not a yearly figure.”

  8. Product-name dual identity — “Salam Healthier Future Assurance” vs “SHIFA Signature”. Sun Life recently refreshed the consumer-facing brand. Field collateral, social posts, prior-customer policy documents, and the agent quote tool may carry either name. Customers reading the product page today see “Salam Healthier Future Assurance” but may have heard “SHIFA Signature” from a prior conversation or competing agent. Agents must (a) confirm both names refer to the same underwritten product (RIPLAY code Agency_v.1/SLFI/2026, product code PM/B/SHIFA/04/2026), (b) note that the policy document and OJK approval reference are the contractual identifiers — not the marketing name, and © update their own field collateral as Sun Life publishes refreshed material. Until Sun Life issues a successor RIPLAY explicitly closing the product, both names remain valid references to one product.


9. Quick-Reference Spec Card


HEADER

Product

Salam Healthier Future

Assurance (also known as

SHIFA Signature)

Type

Asuransi kesehatan syariah

(comprehensive)

Insurer

PT Sun Life Financial

Indonesia, Syariah Division

RIPLAY

Agency_v.1/SLFI/2026

Code

PM/B/SHIFA/04/2026

Channel

Agency

OJK

Approved and registered

BASIC / TERMS

Policyholder age

18 - 80 yrs

Insured age

30 days - 70 yrs

Coverage term

1 year, annual

renewable to

insured age 100

Payment term

Max to insured

age 99

Frequency

Mthly / Qtrly /

Semi / Annual

Min contribution

Rp 6,304,000/yr

(plan dependent)

Sample case

Male 40, Indo 1

= Rp 10,316,000/yr

Plans

7 tiers - Indo 1,

Indo 2, Asia 1,

Asia 2, Asia

Plus 1, Asia

Plus 2, Worldwide

1 policy / insured

BENEFITS

ANNUAL LIMIT (per policy yr)

Indo 1:Rp 4.0B

Indo 2:Rp 5.0B

Asia 1:Rp 6.0B

Asia 2:Rp 7.0B

Asia Plus 1:Rp 8.0B

Asia Plus 2:Rp 10.0B

Worldwide:Rp 15.0B

LIMIT BOOSTER (lifetime once)

Indo 1:Rp 8.0B aggregate

Indo 2:Rp 12.0B

Asia 1:Rp 15.0B

Asia 2:Rp 17.5B

Asia Plus 1:Rp 20.0B

Asia Plus 2:Rp 30.0B

Worldwide:Rp 35.0B

ROOM RATE / DAY (max)

Indo 1:Rp 600K (twin)

Indo 2:Rp 1.1M (single)

Asia 1:Rp 700K (twin)

Asia 2:Rp 1.2M (single)

Asia Plus 1:Rp 1.1M (twin)

Asia Plus 2:Rp 1.65M (single)

Worldwide:Rp 2.5M (single)

Cap:365 days/policy year

DEATH BENEFIT

Rp 20,000,000 (flat all plans)

Modest by design - this is a

health product not a life

product.

INPATIENT

ICU/HCU/PICU:Sesuai tagihan, 365 days/yr cap

Surgery:Sesuai tagihan

Robotic surg:Rp 75M-400M cap by plan (yearly)

Organ trans.:Sesuai tagihan

Doctor visits:3/day max

Misc room:Sesuai tagihan

OUTPATIENT

Pre-admission outpt (within

30 days): Sesuai tagihan Post-discharge outpt (within

90 days): Sesuai tagihan Cancer rad/chemo (outpt): Sesuai tagihan Cancer immuno/target/hormonal

(outpt): Sesuai tagihan (consult+drugs excluded)

Dialysis outpt:Sesuai tagihan

Day surgery:Sesuai tagihan

Telehealth:3 consults/treatment (Indo-domestic only)

TCM post-discharge:10 visits (MY/ID/SG only) Eye outpt (AMD/cataract/etc.): Rp 20-40M/eye/yr by plan

Physio/OT/speech:20 sessions/yr, Rp 1M-2.5M/session by plan Accident outpt+dental (24-hr / 30-day window): Sesuai tagihan Palliative (outpt + inpt): Rp 75M-500M/yr by plan Stroke/cancer/CABG check-up

(5 yrs post): Rp 22.5M-50M/yr

MEDICAL SUPPORT

Ambulance:Sesuai tagihan (in annual limit)

Accommodation:Rp 450K-2M/day, 60 days/yr (overseas only)

Home care:Rp 450K-2M/day, 60 days/yr

Vaccination:Rp 1M-3M/yr (tetanus, rabies, snakebite)

Psychiatrist:Sesuai tagihan (stroke/cancer/ CABG only)

Side-effects:Rp 1.5M-4M/yr (chemo/radio/etc)

Medical report:Rp 500-1,500K per treatment

NO-CLAIM BENEFIT

Yr 1 claim-free:5% off next yr

Yr 2 claim-free:10% off

Yr 3+ claim-free:15% off Resets on any approved claim. Lapse + reinstatement disqualifies for that yr; can re-accrue.

WAITING PERIODS

Masa Tunggu standard

30 cal days

from Policy Inception OR last

Reinstatement OR plan-change

date (whichever latest).

During Masa Tunggu

benefits not

payable except Accident or

Force Majeure.

12-MONTH PENYAKIT KHUSUS

EXCLUSION (from inception or

last reinstatement) for:- All forms of hernia incl HNP - Endometriosis, fibroid, etc - TB, asthma, COPD - Anal fistula, haemorrhoid - Diabetes, gallstones, all Hepatitis (ex Hep A), cirrhosis - Tonsils, adenoid - Urinary tract stones/inflam - Sinus, septum, turbinate - Thyroid disorders - Gastritis, GERD, ulcers - Cataract, glaucoma, retina, macular degen - Hallux valgus - Epilepsy (ex accident) - All spinal incl HNP, disc prolapse, back pain - Hypertension, headache, migraine, vertigo - Blood disorders (non- congenital), autoimmune - Knee/hip incl bone, joint, muscle (ex fracture) - All polyps, cysts, tumours (benign + malignant) - Kidney failure - Coronary artery disease - Cerebrovascular incl TIA, Stroke

EXCLUSIONS NOTABLE

- Pre-existing conditions

(except in writing)

- HIV/AIDS

- Drug/alcohol use, abuse

- Pregnancy, childbirth,

fertility, contraception

- Mental/psychiatric

- Congenital

- Cosmetic, dental (ex acc),

refraction tests

- Experimental, alternative,

preventive

- Sleep apnoea, snoring,

hyperhidrosis, stem cell

- War, terror, nuclear

- Hazardous sports incl

martial arts, skydiving,

diving, climbing

- Suicide, self-harm

- Criminal acts

RISIKO SENDIRI / CO-PAY

No explicit Sun-Medical-Saver-

style per-episode co-payment in

the published RIPLAY today.

ROOM-UPGRADE PRORATA acts as

de facto co-pay

if participant

takes a room above plan entitle-

ment, all non-ambulance benefits

prorated from day 1 by formula

(Eligible room rate / Used

room rate) x insured bill

OR plan-benefit amount,

whichever is lower.

POJK 36/2025 awareness

a future

RIPLAY refresh may add an

explicit co-payment line.

POLICY MECHANICS

Free-look

standard (per Polis)

Grace period (Tenggang)

60

calendar days from contribution

due date before lapse.

Reinstatement (Pemulihan Polis)

within 1 year of lapse and

insured < age 70.

Coordination of Benefits

Pengelola pays balance after

other policies / BPJS settle.

Contribution review

at each

Ulang Tahun Polis; not

guaranteed; 30 working days

notice before change.

Plan change

at Ulang Tahun

Polis only; subject to

re-underwriting.

Cashless

at Preferred Hospital

network domestic + partner

network abroad.

Reimbursement claim deadline

30 calendar days from

treatment end.

Death claim deadline

90 calendar days from death.

Free Look refund

Contribution

paid minus Ujrah-related

costs (incl medical check

if any).

SHARIA STRUCTURE

Akad 1

Tabarru' - participant

contribution as hibah

(donation) to Dana

Tabarru' (risk-sharing

pool). Claims paid

from this pool, not

Sun Life balance sheet.

Akad 2

Wakalah bil Ujrah -

Sun Life acts as wakil

(appointed manager)

of Dana Tabarru' for

a transparent fee

(Ujrah).

Tabarru' / Ujrah % by plan

Indo 1:53% / 47%

Indo 2:54% / 46%

Asia 1:52% / 48%

Asia 2:54% / 46%

Asia Plus 1:52% / 48%

Asia Plus 2:54% / 46%

Worldwide:51% / 49%

Policy print Ujrah

Rp 150,000

if hardcopy elected.

Surplus Underwriting nisbah

Pemegang Polis:50%

Pengelola:40%

Dana Tabarru':10%

Conditions:policy >=12 months, zero claims in period, all contributions paid, policy active at payout date. < Rp 50K share -> social institution.

Qardh

Sun Life advances

interest-free loan to Dana

Tabarru' if deficit; repaid

from future surplus.

DPS oversight

standard for

Sun Life Syariah products

(Dewan Pengawas Syariah).

RBC Syariah

220% (30 Sept

2025) vs 120% regulatory

minimum.

Distribution

16 KPM Syariah

offices nationwide; total

Sun Life Indonesia assets

Rp 19.74 trillion (audited).

BRAND NAME CONTINUITY

Marketing name (current)

Salam Healthier Future

Assurance (SHIFA) - Signature

Marketing name (prior)

SHIFA Signature

Both refer to same product;

policy code PM/B/SHIFA/04/2026

is the contractual identifier.

URL slug detected 2026-05-28

/syariah/agency-syariah/

health-protection/

salam-healthier-future-assurance/

10. Action Items for Legacy Income (next 30 days)

1. Update agent collateral to dual-name format (Week 1). Sun Life’s brand refresh creates field-collateral disambiguation work. Update Legacy Income’s internal product reference card to use “Salam Healthier Future Assurance (SHIFA Signature)” as the consistent format — leading marketing name, prior name in parentheses. Brief all Sun Life-syariah-trained agents that both names refer to the same product (policy code PM/B/SHIFA/04/2026) and that they should be ready to bridge prior customer references to “SHIFA Signature” with the new branding without confusion.

2. Build a Signature vs AlliSya Flexi Medical Syariah head-to-head battlecard (Week 1-2). Salam Healthier Future Assurance is positioned in the same affluent syariah-comprehensive-health shelf where Allianz AlliSya competes. Legacy Income agents will encounter Signature in cross-comparison conversations. Build a one-page battlecard covering: annual limit ranges, global reach (the genuine Signature advantage at the Worldwide tier including US 100%), renewal ceiling (Signature 100 vs AlliSya 80), Ujrah rate at parity tier, and contribution comparison. Highlight where AlliSya legitimately wins — do not run a partisan piece, run an honest one. Target distribution: all active Legacy Income syariah-trained agents by end of week 2.

3. Run a Tabarru’ deficit / Qardh disclosure training session (Week 2). Section 8 item #2 is the syariah-specific compliance disclosure most likely to be skipped in the field. Run a 45-minute training where agents practise saying out loud: “Dana Tabarru’ bisa defisit; Sun Life kasih Qardh tanpa bunga; tapi struktur ini bukan bebas risiko.” Audio-record the exercise; review three agents’ phrasing for natural delivery without over-explanation. Goal: every agent who pitches any syariah comprehensive health product (Signature, Healthcare Solution, AlliSya) can deliver this disclosure unprompted within 30 seconds.

4. Develop a structured “tier-fit interview” before any Signature recommendation (Week 1). The premium-tier mis-positioning risk (Section 8 item #5) is real. Build a 7-question intake form agents complete before recommending Signature, covering: household monthly income, primary residence country, travel pattern (Asia / Asia Plus / Worldwide), employer health card status, BPJS status, existing private health policies, and explicit syariah preference rationale. Customers whose answers don’t justify Signature must be redirected to Sun Healthcare Solution Syariah or SHIFA Essential per the Decision Framework. File the intake form with every signed SPAJ.

5. Monitor for the next Signature RIPLAY refresh (POJK 36/2025 co-payment update) (Week 3-4). Section 8 item #1 flags the most likely product change in 2026: a formal Sun-Medical-Saver-equivalent co-payment clause added to align with POJK 36/2025 effective January 2026. The brand rename may be the first phase of a broader product refresh — the next refresh may also bring an updated co-payment clause. Set a calendar reminder for monthly check of the Sun Life Indonesia agency-syariah product page (https://www.sunlife.co.id/id/syariah/agency-syariah/health-protection/salam-healthier-future-assurance/). When the RIPLAY version changes from Agency_v.1/SLFI/2026, trigger a refresh of this brief and re-run agent training on the updated co-payment disclosure. Customers written between now and the refresh point may sit under a transitional regime — confirm policy terms with Sun Life agency support before quoting.


This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official RIPLAY and brochure as downloaded 2026-05-28 (PDFs byte-identical to the 2026-05-12 documents that supported the prior shifa-signature brief); the policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.

Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.